Clark Eliana, EVP and Chief Technical Officer at Intellia Therapeutics ($NTLA), sold shares on the open market three times over the past year for a total of $106,000. Her most recent sale occurred on March 2, 2026. These transactions rank 9,482nd among 11,678 insiders in our database, well below the average sale amount of 8.6 million across 6.4 transactions per insider. Clark Eliana made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 10505 | $0.00 | 10,505.0000 | 115,829,926 | 9999.99% | 0.01% |
| March 2, 2026 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 607 | $13.78 | 93,864.0000 | 115,829,926 | 0.64% | 0.00% |
| March 1, 2026 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 7353 | $0.00 | 94,471.0000 | 115,829,926 | 8.44% | 0.01% |
| Jan. 5, 2026 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 9515 | $9.21 | 87,118.0000 | 115,829,926 | 9.85% | 0.01% |
| July 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 1022 | $9.82 | 95,369.0000 | 103,517,460 | 1.06% | 0.00% |
| March 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 45714 | $0.00 | 45,714.0000 | 103,517,460 | 9999.99% | 0.04% |
| March 1, 2025 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 32000 | $0.00 | 96,048.0000 | 103,517,460 | 49.96% | 0.03% |
| March 4, 2025 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 679 | $8.99 | 95,369.0000 | 103,517,460 | 0.71% | 0.00% |
| Jan. 3, 2025 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 7422 | $12.18 | 64,048.0000 | 0 | 10.38% | 0.00% |
| Jan. 2, 2025 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 556 | $12.03 | 71,470.0000 | 0 | 0.77% | 0.00% |
| July 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 405 | $22.93 | 71,470.0000 | 0 | 0.56% | 0.00% |
| March 4, 2024 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 605 | $32.99 | 71,470.0000 | 0 | 0.84% | 0.00% |
| March 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 45072 | $0.00 | 45,072.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 31230 | $0.00 | 72,075.0000 | 0 | 76.46% | 0.00% |
| Jan. 3, 2024 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 307 | $30.12 | 45,146.0000 | 0 | 0.68% | 0.00% |
| Jan. 3, 2024 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 4301 | $29.46 | 40,845.0000 | 0 | 9.53% | 0.00% |
| July 3, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 360 | $40.51 | 45,146.0000 | 0 | 0.79% | 0.00% |
| June 20, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | M | Common Stock | 5000 | $12.27 | 50,146.0000 | 0 | 11.08% | 0.00% |
| June 20, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 5000 | $45.00 | 45,146.0000 | 0 | 9.97% | 0.00% |
| June 20, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 57,750.0000 | 0 | 7.97% | 0.00% |
| March 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 24539 | $0.00 | 39,012.0000 | 0 | 169.55% | 0.00% |
| March 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 6134 | $0.00 | 45,146.0000 | 0 | 15.72% | 0.00% |
| March 1, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 34674 | $0.00 | 34,674.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 1692 | $37.21 | 14,473.0000 | 0 | 10.47% | 0.00% |
| Jan. 3, 2023 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 231 | $34.48 | 16,165.0000 | 0 | 1.41% | 0.00% |
| July 1, 2022 | Intellia Therapeutics, Inc. | $NTLA | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 105 | $51.74 | 16,165.0000 | 0 | 0.65% | 0.00% |